ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,702,000 | -26.4% | 940,400 | +576.8% | 0.68% | -51.4% |
| Q4 2018 | $6,392,000 | +43.5% | 138,958 | +38.4% | 1.41% | +146.7% |
| Q3 2018 | $4,453,000 | -23.6% | 100,369 | -32.5% | 0.57% | -36.7% |
| Q2 2018 | $5,828,000 | +114.1% | 148,704 | +295.0% | 0.90% | +455.6% |
| Q1 2018 | $2,722,000 | -70.9% | 37,646 | -73.5% | 0.16% | -81.0% |
| Q4 2017 | $9,361,000 | +124.1% | 142,185 | +70.6% | 0.85% | +212.5% |
| Q3 2017 | $4,178,000 | +887.7% | 83,357 | +338.7% | 0.27% | +1087.0% |
| Q4 2015 | $423,000 | -25.3% | 19,000 | -20.8% | 0.02% | 0.0% |
| Q3 2015 | $566,000 | +22.2% | 23,990 | +379.8% | 0.02% | +21.1% |
| Q1 2015 | $463,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |